0 Comments
0 Shares
242 Views
0 Reviews
Search
Discover new people, create new connections and make new friends
-
Please log in to like, share and comment!
-
Are Surgical Innovations Improving Outcomes in Lung Cancer Treatment?Lung Cancer Surgery Market Summary: According to the latest report published by Data Bridge Market Research, the Lung Cancer Surgery Market CAGR Value This global Lung Cancer Surgery Market report is a wonderful guide to achieve an information or key data about market, emerging trends, product usage, motivating factors for customers, competitor strategies, brand...0 Comments 0 Shares 166 Views 0 Reviews
-
Asia-Pacific Lung Cancer Screening Software Market Demand: Growth, Share, Value, Size, and Insights"Executive Summary Asia-Pacific Lung Cancer Screening Software Market Size and Share Forecast Data Bridge Market Research analyzes that the Asia-Pacific lung cancer screening software market is expected to reach the value of USD 14,981.84 thousand by 2029, at a CAGR of 20.8% during the forecast period. Cloud based solutions accounts for largest mode of delivery segment in the market....0 Comments 0 Shares 815 Views 0 Reviews
-
Brigatinib API Market to Reach 89.7 Million by 2034 Driven by Rising Lung Cancer CasesAccording to a new report from Intel Market Research, the global Brigatinib API market was valued at USD 42.5 million in 2025 and is projected to reach USD 89.7 million by 2034, growing at a robust CAGR of 8.1% during the forecast period (2026–2034). This growth is propelled by the increasing global incidence of non-small cell lung cancer, particularly ALK-positive cases among...0 Comments 0 Shares 188 Views 0 Reviews
-
Europe Lung Cancer Screening Software Market Opportunities: Growth, Share, Value, Size, and Scope"Detailed Analysis of Executive Summary Europe Lung Cancer Screening Software Market Size and Share Data Bridge Market Research analyzes that the Europe lung cancer screening software market is expected to reach the value of USD 27,518.34 thousand by 2029, at a CAGR of 19.6% during the forecast period. Cloud based solutions accounts for largest mode of delivery segment in the market....0 Comments 0 Shares 834 Views 0 Reviews
-
Europe Lung Cancer Therapeutics Market: Insights and Competitive AnalysisExecutive Summary Europe Lung Cancer Therapeutics Market Size and Share: Global Industry Snapshot CAGR Value The Europe Lung Cancer Therapeutics Market size was valued at USD 2.33 billion in 2025 and is expected to reach USD 3.97 billion by 2033, at a CAGR of 6.90% during the forecast period Each of the topics covered in the Europe Lung Cancer...0 Comments 0 Shares 491 Views 0 Reviews
-
How Is the Europe Non-Small Cell Lung Cancer Diagnostics Market Advancing with Precision Oncology?"Executive Summary Europe Non-Small Cell Lung Cancer Diagnostics Market Research: Share and Size Intelligence CAGR Value The Europe non-small cell lung cancer diagnostics market size was valued at USD 850.07 billion in 2025 and is expected to reach USD 2181.09 billion by 2033, at a CAGR of 12.50% during the forecast period The scope of this Europe...0 Comments 0 Shares 488 Views 0 Reviews
-
How Public Health Policies Can Reduce Lung Cancer Rates in IndiaIn bustling streets from Delhi to small villages in Bihar, lung cancer touches more lives each year, but thoughtful rules from the government could turn the tide. Drawing from fresh 2025 reports, cases might hit over 81,000 in men and 30,000 in women soon, up from lower numbers a decade back. It's not just statistic families facing tough days because of smoke from cigarettes or dirty air. Let's...0 Comments 0 Shares 988 Views 0 Reviews
-
Lung Cancer Diagnostics Market Forecast 2025–2033 GrowthLung Cancer Diagnostics Market to Reach US$ 38 Billion by 2033 as Early Detection Demand Grows Lung Cancer Diagnostics Market Size and Forecast 2025–2033 The global lung cancer diagnostics market is expected to witness substantial growth in the coming decade as healthcare systems increasingly focus on early cancer detection and precision medicine. According to Renub Research, the...0 Comments 0 Shares 480 Views 0 Reviews
-
Lung Cancer Screening Software Market Future Scope: Growth, Share, Value, Insights, and Trends"Executive Summary Lung Cancer Screening Software Market Size, Share, and Competitive Landscape The global lung cancer screening software market size was valued at USD 47.38 billion in 2024 and is expected to reach USD 195.75 billion by 2032, at a CAGR of 19.40% during the forecast period. To attain knowhow of market landscape, brand awareness, latest...0 Comments 0 Shares 951 Views 0 Reviews
-
Lung Cancer Screening Software Market Industry Statistics: Growth, Share, Value, Insights, and TrendsIntroduction Lung cancer remains one of the leading causes of cancer-related mortality worldwide, accounting for a significant share of global cancer deaths each year. The disease is often diagnosed at advanced stages due to the absence of early symptoms, which substantially reduces survival rates. As a result, early detection has become a critical focus area for healthcare systems,...0 Comments 0 Shares 799 Views 0 Reviews
-
Lung Cancer Screening Software Market Industry Statistics: Growth, Share, Value, Insights, and TrendsIntroduction The Global Lung Cancer Screening Software Market is witnessing significant growth, driven by the increasing prevalence of lung cancer and the need for early detection and diagnosis. Lung cancer remains one of the leading causes of cancer-related mortality worldwide, and timely intervention is crucial to improving patient outcomes. Lung cancer screening software leverages...0 Comments 0 Shares 1K Views 0 Reviews
-
Anti-Cancer Drug Market Companies: Growth, Share, Value, Size, and Insights"Executive Summary Anti-Cancer Drug Market: Share, Size & Strategic Insights Data Bridge Market Research analyses that the global anti-cancer drug market which was USD 1,20,000.00 million in 2022, would rocket up to USD 2,97,000.00 million by 2030, and is expected to undergo a CAGR of 12.0% during the forecast period. The Anti-Cancer Drug report provides CAGR values along with its...0 Comments 0 Shares 5K Views 0 Reviews
-
Authentic Gefitinib Tablets IP 250 mg Exporter in Quezon CityThe Philippines requires effective cancer treatment access because Gefitinib Tablets IP 250 mg serve as an important component of targeted therapy. The healthcare industry uses these Gefitinib Tablets because they deliver dependable results which make them suitable for extended treatment needs of patients and their medical teams. Many individuals select Gefitinib Tablets IP 250 mg because they...0 Comments 0 Shares 146 Views 0 Reviews1
-
Brigatinib API Market Growing at 8.1% CAGR Through 2034 GloballyAccording to a new report from Intel Market Research, the global Brigatinib API market was valued at USD 42.5 million in 2025 and is projected to reach USD 89.7 million by 2034, growing at a robust CAGR of 8.1% during the forecast period (2026–2034). This growth is propelled by the increasing global incidence of non-small cell lung cancer, particularly ALK-positive cases among...0 Comments 0 Shares 518 Views 0 Reviews
-
Crizotinib Drugs Market Growing at 6.7% CAGR Through 2034According to a new report from Intel Market Research, the global Crizotinib Drugs market was valued at USD 582.4 million in 2025 and is projected to reach USD 1,043.7 million by 2034, growing at a CAGR of 6.7% during the forecast period (2026–2034). This growth is propelled by the rising global incidence of lung cancer, increasing adoption of molecular diagnostic testing for genetic...0 Comments 0 Shares 313 Views 0 Reviews
-
Global Multi-target MET TKIs Market Growing at 7.6% CAGR Through 2034According to a new report from Intel Market Research, the global Multi-target MET TKIs market was valued at USD 1.52 billion in 2025 and is projected to reach USD 3.18 billion by 2034, growing at a CAGR of 7.6% during the forecast period (2026–2034). This growth is propelled by the rising global incidence of non-small cell lung cancer and medullary thyroid cancer, precision oncology...0 Comments 0 Shares 302 Views 0 Reviews
-
Global Selpercatinib Capsules Market Growing at 7.8% CAGR Through 2034According to a new report from Intel Market Research, the global Selpercatinib Capsules market was valued at USD 420 million in 2025 and is projected to reach USD 820 million by 2034, growing at a CAGR of 7.8% during the forecast period (2026–2034). This growth is propelled by the increasing prevalence of RET-altered cancers, growing adoption of biomarker-driven therapies, and...0 Comments 0 Shares 389 Views 0 Reviews
More Results